STERIS plc

Healthcare · Medical Devices

208.80$ -0.6% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

STERIS plc (STE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,493 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement STE
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	646	647	681	608	634	662	716	639	679	696	768	697	737	774	823	669	756	809	874	968	1,197	1,209	1,211	1,156	1,201	1,216	1,385	1,183	1,238	1,298	1,116	1,280	1,329	1,371	1,481	1,391	1,460	1,496	1,588	1,493	6,038
Cost of Revenue	399	389	401	352	368	384	423	370	394	409	433	391	418	443	459	382	426	463	492	542	717	671	639	639	668	694	797	654	692	738	668	707	750	760	839	763	814	841	891	809	3,355
Gross Profit	248	258	280	256	266	278	293	269	285	287	335	306	319	331	364	287	330	346	382	426	480	538	572	518	532	521	588	529	546	560	449	572	579	610	641	628	646	656	697	684	2,683
Research & Development	15	15	16	14	14	15	18	16	16	15	16	16	16	16	17	16	16	16	18	18	19	25	26	25	25	26	26	25	26	25	25	26	27	27	28	26	28	30	29	29	115
Selling, General & Administrative	156	138	193	166	165	160	135	158	162	160	162	179	176	173	174	155	18	182	214	394	345	311	454	335	323	305	314	359	381	361	152	336	329	335	312	354	350	352	352	370	1,424
Total Operating Expenses	178	232	221	170	168	175	179	175	178	217	194	196	192	189	206	172	189	199	236	412	364	335	480	359	839	331	363	331	355	334	203	387	359	365	425	382	380	382	381	398	1,541
Operating Income	70	26	59	86	99	103	114	94	107	70	141	110	127	142	158	116	141	147	146	14	117	203	92	158	-306	191	225	198	192	226	245	186	220	245	216	246	268	271	317	286	1,142
Interest Expense	11	11	12	12	13	12	13	12	11	12	11	11	10	9.8	9.8	9.5	8.7	8.9	10	22	23	23	22	23	27	29	30	32	37	39	36	30	20	19	17	16	15	15	15	16	61
Pre-Tax Income	59	15	47	74	87	92	101	83	95	58	133	99	117	134	148	109	134	139	138	-29	90	182	71	135	-333	160	195	167	156	190	215	175	195	229	197	232	253	258	305	274	1,089
Income Tax Expense	19	20	21	16	23	-3.4	28	13	18	9.3	25	15	22	29	25	20	28	25	49	-7.1	20	39	19	24	-18	37	8.2	36	35	41	43	35	44	55	50	54	61	64	84	73	281
Net Income	40	-5.0	26	58	64	95	74	70	77	48	109	85	95	105	123	88	106	115	87	-22	70	143	52	111	-315	123	187	124	115	141	-1.4	145	150	174	146	177	192	193	220	200	805
EBITDA	120	58	112	130	146	149	159	141	153	152	194	157	177	193	209	167	197	34	207	77	231	324	327	298	-173	600	368	337	345	369	386	318	330	374	337	367	390	391	680	349	1,810

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings